CODET Vision Institute Hosts Advanced Symposium on Ocular Surface & Dry Eye Disease
Leading ophthalmologists gathered at CODET Vision Institute for an educational symposium on advanced ocular surface and dry eye management.

On May 16, 2026, CODET Vision Institute welcomed ophthalmologists and eye care professionals to an educational symposium focused on the latest advances in ocular surface disease and dry eye treatment.
Titled “Bad Surface, Bad Outcome: Advanced Strategies in Ocular Surface and Dry Eye,” the event brought together specialists from multiple ophthalmic subspecialties for an afternoon of academic discussion, innovation, and collaboration in Tijuana.
The symposium was moderated by Dr. Erik Navas Villar, Co-Director of the Cornea Service at CODET Vision Institute, who welcomed attendees and guided the scientific program throughout the event.
A Multidisciplinary Approach to Ocular Surface Disease
The symposium highlighted how ocular surface health plays a critical role in achieving successful outcomes across multiple ophthalmic procedures and treatments.
Throughout the program, speakers explored the newest approaches for diagnosing and managing dry eye disease, corneal surface disorders, and related surgical challenges.
Topics presented during the symposium included:
- Simultaneous pterygium surgery with Light Adjustable Lens implantation
- Advances in lubricants for dry eye treatment
- Corneal surface optimization before refractive surgery
- IPL therapy for evaporative dry eye
- Emerging therapies for severe dry eye, including blood-derived treatments
- Mini SLET techniques for recurrent pterygium management

Leading Ophthalmology Specialists Shared Clinical Expertise
The academic program featured presentations from recognized specialists, including:
- Dr. Arturo Chayet (Medical Director at CODET Vision Institute)
- Dr. Haber Olguín
- Dr. Pablo Limón
- Dr. Denisse Pinkus
- Dr. Ned Dávila
- Dr. César Hernández
Each session focused on practical clinical strategies, technological innovation, and evolving therapies designed to improve patient outcomes and quality of life.
The event also provided an opportunity for networking and professional collaboration among ophthalmologists and healthcare professionals from the region.
